A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations

Alexander G Mathioudakis; Julie Janner; Mia Moberg; Pablo Alonso-Coello; Jørgen Vestbo

doi:10.1183/23120541.00136-2019

A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations

ERJ Open Res. 2019 Nov 15;5(4):00136-2019. doi: 10.1183/23120541.00136-2019. eCollection 2019 Oct.

Authors

Alexander G Mathioudakis^{1

2}, Julie Janner³, Mia Moberg³, Pablo Alonso-Coello⁴, Jørgen Vestbo^{1

2}

Affiliations

¹ Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
² North West Lung Centre, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.
³ Dept of Respiratory Medicine, Hvidovre University Hospital, Hvidovre, Denmark.
⁴ Cochrane Iberoamérica, Biomedical Research Institute Sant Pau (IIB Sant Pau-CIBERESP), Barcelona, Spain.

Abstract

Clinical trials evaluating the management of #AECOPD use different diagnostic criteria for COPD and exacerbations, limiting their comparability http://bit.ly/33eIUUX.